is glp 1 safe with kidney disease GLP-1 agonists in the treatment of chronic in type 2 diabetes and obesity Kidney Outcomes With Glucagon-Like Peptide-1
Description
The full details are presented in the Data S1
So that scares me a little
Accessed 24 Sep 2015
The 2024 multi-society guidance shifted to continuation for most patients with targeted precautions for higher-risk patients
Front Public Health
It enhances the appetite-suppressing effects of GLP-1 medicines by promoting satiety
